SUCAMPO PHARMACEUTICALS, INC. Zu einer Liste hinzufügen
Anteilsklasse
| Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
|---|---|---|---|---|---|
| Aktie A | 1 | 46 636 924 | 45 389 949 ( 97,33 %) | 227 266 ( 0,4873 %) | 97,33 % |
Unternehmenskontakt
Sucampo Pharmaceuticals, Inc.
805 King Farm Boulevard Suite 550
20850, Rockville
+301-961-3400
http://sucampo.com
Konzerngesellschaften
| Name | Kategorie und Branche |
|---|---|
Sucampo Pharma LLC
 Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. |
Miscellaneous Commercial Services
|
Sektor
| % 1. Jan. | Kap. | |
|---|---|---|
| -1,38 % | 104 Mrd. | |
| +6,75 % | 97,47 Mrd. | |
| +5,71 % | 22,25 Mrd. | |
| -12,52 % | 21,68 Mrd. | |
| -9,70 % | 18,2 Mrd. | |
| -39,98 % | 17,02 Mrd. | |
| -10,00 % | 16,36 Mrd. | |
| +7,87 % | 14,39 Mrd. | |
| +36,90 % | 12,37 Mrd. |
